
Rx Rundown: Sarepta Therapeutics, Juul, Pfizer and more
Deals: AbbVie and Ichnos Glenmark Innovation entered a licensing agreement for nearly $2 billion, giving AbbVie access to a myeloma antibody. Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 …